ARTICLE | Clinical News
NMP22 BladderCheck test regulatory update
February 23, 2004 8:00 AM UTC
MZT received CE Mark approval in the EU for its NMP22 products, including NMP22 BladderChek to detect the bladder cancer matrix protein NMP22 in urine. ...